A Dark Vector Cognition product

Item 5. Other Information

3K characters. Original on sec.gov ·

Item 5. Other Information

The 1 table in Item 5. Other Information as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Rule 10b5-1 Trading Plans

Our policy governing transactions in our securities by our directors, officers, and employees permits our officers, directors and employees to enter into trading plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The following table describes the written plans for the sale of our securities adopted by our executive officers and directors during the first quarter of 2024, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1 (each, a “Trading Plan”).

Name and TitleDate of Adoption of Trading PlanScheduled Expiration Date of Trading Plan (1)Maximum Shares Subject to Trading Plan
E. Morrow "Morrey" Atkinson, III EVP, Chief Technical Operations Officer, Head of Biopharmaceutical Sciences and Manufacturing Operations2/22/20242/28/202525,290(2)
Jonathan Biller EVP, Chief Legal Officer2/13/20244/30/20259,825(2)
Carmen Bozic EVP, Global Medicines Development and Medical Affairs, and Chief Medical Officer2/27/20241/31/202513,680
Reshma Kewalramani Chief Executive Officer and President2/7/20245/20/202596,388(2)
Ourania "Nia" Tatsis EVP, Chief Regulatory and Quality Officer2/29/20245/1/20259,484(2)
Charles F. Wagner, Jr. EVP, Chief Financial Officer2/26/20241/31/20256,500
Bruce Sachs Director2/12/20242/28/202512,368
(1) A Trading Plan may expire on an earlier date if all contemplated transactions are completed before such Trading Plan’s expiration date, upon termination by broker or the holder of the Trading Plan, or as otherwise provided in the Trading Plan. (2) The maximum shares listed has not been reduced by the number of shares of common stock that will be withheld to satisfy tax withholding obligations at future vesting dates because such number of shares is not yet determinable.

Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits